Berlin, Germany

Christine Lehmann

This inventor holds 1 USPTO granted patent. Top assignee: Max-Delbru/ Ck-Centrum. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christine Lehmann. Retrieved from https://idiyas.com/inventor/christine-lehmann-bkvp9pq9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christine Lehmann: Innovator in Antiviral Compounds

Introduction

Christine Lehmann is a notable inventor based in Berlin, Germany. She has made significant contributions to the field of antiviral compounds, particularly through her innovative research and development.

Latest Patents

Christine holds 1 patent for her work on 2',3'-dideoxynucleoside pyrimidine compounds and carbocyclic analogs. Her patent discloses 2',3'-dideoxynucleoside pyrimidine compounds and 2-thiothymidine carbocyclic derivatives, which are recognized for their potential antiviral activity. These compounds are expected to exhibit antiviral properties similar to those recognized for 2',3'-dideoxynucleoside compounds and their analogs.

Career Highlights

Christine is currently associated with Max-Delbrück Center for Molecular Medicine. Her work has been pivotal in advancing the understanding and development of antiviral therapies.

Collaborations

She has collaborated with notable colleagues, including Eckart Matthes and Klaus Gaertner, contributing to a dynamic research environment.

Conclusion

Christine Lehmann's innovative work in antiviral compounds showcases her dedication to advancing medical science. Her contributions are expected to have a lasting impact on the field of virology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…